Rhizophora apiculata

Rhizophora apiculata

Rhizophora apiculata is a mangrove tree traditionally found in coastal areas of Southeast Asia. While it has significant ecological importance, particularly for carbon storage and habitat provision, there are no recorded traditional uses for this plant in medicine or other cultural practices. Scientific evidence suggests that Rhizophora apiculata may have potential anti-inflammatory properties based on pharmacoinformatics analysis, which predicted overlapping inflammation-related targets. Additionally, the species showed restricted transport of zinc, accumulating it in roots while shielding aerial tissues under increasing sediment loads, indicating a unique adaptation to its environment. There is also limited evidence suggesting possible anticancer activity among six mangrove species studied, but specific findings for Rhizophora apiculata alone are not detailed. Safety concerns and drug interactions related to the use of Rhizophora apiculata have not been recorded in existing literature, indicating that it may be relatively safe. However, further research is needed to fully understand its potential benefits and risks.

At a glance
Best evidence
D
Cautions

Informational only. Traditional use does not mean proven effectiveness. Evidence and safety vary — check the cited sources.

What the science says

  • The study found that aboveground carbon stock in mangrove forests of Samut Songkhram Province, Thailand, had reduced by 44.99% compared to the 2019 baseline due to land-use changes. D PMID
  • The study predicted that Rhizophora apiculata may interact with 70 inflammation-related targets, including EGFR, COX2, JAK2, and MAPK14. D PMID
  • Rhizophora apiculata showed restricted transport of zinc, accumulating it in roots but shielding aerial tissues under increasing sediment loads. D PMID
  • Rhizophora apiculata showed no significant cytotoxic effects against cancer cell lines in this study. D PMID

Frequently asked questions

What is Rhizophora apiculata?

Rhizophora apiculata (Rhizophora apiculata) is a plant documented in FolkKB's traditional-medicine reference, drawn from sourced literature and cross-checked against the evidence.

What does the scientific evidence say about Rhizophora apiculata?

4 sourced findings are recorded for Rhizophora apiculata; the strongest carries evidence grade D. For example: The study found that aboveground carbon stock in mangrove forests of Samut Songkhram Province, Thailand, had reduced by 44.99% compared to the 2019 baseline due to land-use changes.

How strong is the evidence for Rhizophora apiculata?

The strongest finding for Rhizophora apiculata carries evidence grade D — preliminary or traditional. Grades run A (strongest) to D (preliminary or traditional).

Is Rhizophora apiculata safe? What are the side effects?

No major safety issues are recorded for Rhizophora apiculata in our sources, but the data may be incomplete. Consult a qualified professional before use.

Does Rhizophora apiculata interact with medications?

No drug interactions are recorded for Rhizophora apiculata in our sources. This does not rule them out — check with a pharmacist.

Is Rhizophora apiculata a proven treatment?

No. FolkKB is informational only. Traditional use and early findings are not proof of efficacy or safety — consult a qualified professional and never self-treat.

Sources

  1. T2 Anticancer potential of mangrove derived metabolites: cytotoxicity and phytochemical based studies. literature abstract metadata
  2. T2 Assessment of aboveground carbon stock in mangrove forests using GIS and environmental monitoring: A case study in Samut Songkhram Province, Thailand. literature abstract metadata
  3. T2 Pharmaco-informatics based prediction of anti-inflammatory targets modulated by Rhizophora apiculata. literature abstract metadata
  4. T2 Phytostabilization of potentially toxic elements by mangrove trees in coastal sediments along Pattani Bay, Thailand. literature abstract metadata